The purpose of this study is to test the hypothesis that maternal probiotic supplementation is associated with infant gut microbiome variation and improved neurodevelopmental outcomes as measured by ERP performance in infants of diabetic mothers (IDMs), a cohort that is at-risk for recognition memory abnormalities.
Age range
21 Years – 45 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Infant auditory recognition ERP performance at 1 month: P200 amplitude
Timeframe: 1 month of age
Infant auditory recognition ERP performance at 1 month: Negative slow wave difference score
Timeframe: 1 month of age
Infant visual recognition ERP performance at 6 months: Slow wave difference score
Timeframe: 6 months of age
Infant VEP performance at 6 months: latency to peak of P100
Timeframe: 6 months of age